Global Clot Management Devices Market 2015-2019 - Increase in number of MIS procedures
DUBLIN, July 20, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/cbtn6d/global_clot) has announced the addition of the "Global Clot Management Devices Market 2015-2019" report to their offering.
The global clot management devices market to grow at a CAGR of 5.95% over the period 2014-2019.
A blood clot or thrombus is the end stage of blood coagulation process in hemostasis. Blood clot is the body's response to an injury to prevent bleeding. However, a clot can be harmful when it forms abnormally to obstruct blood flow through healthy blood vessels. This condition is called thrombosis. A blood clot in arteries can lead to heart attack, while blood clot formed in the deep veins can lead to DVT or PE. Clot management devices help in the removal of a clot or dissolving clot in the blood vessels.
The report, the Global Clot Management Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA; it also covers the global clot management devices market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
One of the trends is the increased number of MIS procedures. Surgical procedures expose a patient's blood to foreign surfaces, which may initiate coagulation. DVT and PE are some major complications faced by patients who undergo surgery. MIS reduces patient trauma and recovery time.
According to the report, a rise in awareness of endovascular treatment is one of the primary drivers in this market. Endovascular treatment is a surgical treatment in which microcatheters, embolic coils, and stents are used to remove blood clots.
Further, the report states that the high acceptance of anticoagulant therapy is hindering the growth of the market.
Based on type of devices, the market can be segmented as follows:
- Percutaneous thrombectomy devices
- Embolectomy balloon catheters
- Catheter-directed thrombolysis
- IVCF
- Neurovascular embolectomy devices
Key vendors
- AngioDynamics
- Boston Scientific
- Cook Group
- Stryker
Other prominent vendors
- Acandis
- Argon Medical Devices
- Asid Bonz
- Biosensors International Group
- Control Medical Technology
- Covidien
- DePuy Synthes
- Dispomedica
- Edwards Lifesciences
- EKOS (a BTG International Group company)
- Eurocor
- FBMedical-ISOMed
- iVascular
- LeMaitre Vascular
- Merit Medical
- Phenox
- Straub Medical
- Teleflex
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market overview
03.2 Product offerings
04. Market Research Methodology
04.1 Market research process
04.2 Research methodology
05. Introduction
05.1 Risk factors associated with blood clots
05.2 Epidemiology of VTE
05.3 Pathophysiology of VTE
05.4 Blood clot by type
06. Market Landscape
06.1 Market overview
06.2 Market size and forecast
06.3 Five forces analysis
07. Market Segmentation by Device
08. Geographical Segmentation
09. Americas
09.1 Market size and forecast
10. EMEA
10.1 Economic burden of VTE following major orthopedic surgery in Europe
10.2 Market size and forecast
11. APAC
11.1 Market size and forecast
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive scenario
19.1.1 Key news
19.1.2 Mergers and acquisitions
19.2 Market share analysis 2013
19.3 Other prominent vendors
20. Key Vendor Analysis
20.1 AngioDynamics
20.1.1 Key facts
20.1.2 Business overview
20.1.3 Business segmentation
20.1.4 Business strategy
20.1.5 Revenue segmentation by category of product
20.1.6 Revenue segmentation by geography
20.1.7 Key information
20.1.8 SWOT analysis
20.2 Boston Scientific
20.2.1 Key facts
20.2.2 Business Overview
20.2.3 Business segmentation
20.2.4 Business segmentation by revenue 2013
20.2.5 Business segmentation by revenue 2012 and 2013
20.2.6 Geographical segmentation by revenue 2013
20.2.7 Business strategy
20.2.8 Key developments
20.2.9 SWOT analysis
20.3 Cook Medical
20.3.1 Key facts
20.3.2 Business overview
20.3.3 Key divisions
20.3.4 Geographical segmentation 2013
20.3.5 Business strategy
20.3.6 Recent developments
20.3.7 SWOT analysis
20.4 Stryker
20.4.1 Key facts
20.4.2 Business overview
20.4.3 Business segmentation by revenue 2013
20.4.4 Business segmentation by revenue 2012 and 2013
20.4.5 Geographical segmentation by revenue 2013
20.4.6 Business strategy
20.4.7 Recent developments
20.4.8 SWOT analysis
21.Other Reports in this Series
List of Exhibts: Exhibit 1: Market research methodologyExhibit 2: Risk factors associated with blood clotsExhibit 3: VTE incidences in USExhibit 4: Other incidencesExhibit 5: Types of blood clotExhibit 6: Risk factors for DVTExhibit 7: Risk factors for PEExhibit 8: Global clot management devices market 2014-2019 ($ million)Exhibit 9: Segmentation by deviceExhibit 10: Segmentation of global clot management devices market by geography 2014Exhibit 11: Clot management devices market 2014-2019 ($ million)Exhibit 12: VTE disease burden in EuropeExhibit 13: Total number of VTE events per year within six European countriesExhibit 14: Relative distribution of diagnosed and undiagnosed PE among fatal VTE eventsExhibit 15: Clot management devices market 2014-2019 ($ million)Exhibit 16: Clot management devices market 2014-2019 ($ million)Exhibit 17: Segmentation of global clot management devices market by geography 2014-2019Exhibit 18: Segmentation of global clot management devices market by geography 2014-2019 ($ million)Exhibit 19: Segmentation of global clot management devices market by geography 2014 and 2019Exhibit 20: Segmentation of global clot management devices market by geography 2014 and 2019 ($ million)Exhibit 21: Endovascular treatment of strokeExhibit 22: Clinical evidenceExhibit 23: AngioDynamics: business segmentation by category of productExhibit 24: AngioDynamics: segmentation of revenue by category of product 2014Exhibit 25: AngioDynamics: segmentation of revenue by geography 2014Exhibit 26: Boston Scientific: business segmentation 2013Exhibit 27: Boston Scientific: business segmentation by revenue 2013Exhibit 28: Boston Scientific: business segmentation by revenue 2012 and 2013 ($ million)Exhibit 29: Boston Scientific: geographical segmentation by revenue 2013Exhibit 30: Cook Medical: key divisionsExhibit 31: Cook Medical: geographical segmentation 2013Exhibit 32: Stryker: business segmentation by revenue 2013Exhibit 33: Stryker: business segmentation by revenue 2012 and 2013 ($ million)Exhibit 34: Stryker: geographical segmentation by revenue 2013
Companies Mentioned
- AngioDynamics Inc - Boston Scientific Corp - Cook Medical - Stryker Corp. - Acandis GmbH & Co. KG - Argon Medical Devices - Asid Bonz - Biosensors International Group - Control Medical Technology - Covidien - DePuy Synthes - Dispomedica - Edwards Lifesciences - EKOS - a BTG International group company - Eurocor - FBMedical-ISOMed - iVascular - LeMaitre Vascular - Merit Medical Systems - Phenox GmbH - Straub Medical AG - Teleflex
For more information visit http://www.researchandmarkets.com/research/cbtn6d/global_clot
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Laura Wood, +353-1-481-1716, press@researchandmarkets.net
Share this article